GZYK(SZ:002524) Zheng Quan Zhi Xing·2025-08-04 16:12Summary of Key Points Core Viewpoint The announcement details the first unlock period of the restricted stock incentive plan for Guangzheng Eye Hospital Group Co., Ltd., indicating that the conditions for unlocking have been met, allowing 1,957,500 shares to be released for trading, which represents 0.3776% of the company's total share capital [1][2][7]. Group 1: Incentive Plan Overview - The incentive plan involves a total of 221 participants, with the first unlock period allowing for the release of 1,957,500 shares [1][2]. - The plan's first unlock period is defined as starting from the completion of the grant registration and lasting until the last trading day within 24 months [7][10]. - The total number of restricted shares granted was adjusted from 919,994.6 thousand shares to 914,494.6 thousand shares due to the departure of three participants [6]. Group 2: Performance Conditions - The performance assessment for the unlock conditions is based on the company's revenue growth compared to the 2022 fiscal year, with specific targets set for each assessment year [9][10]. - The unlocking ratio is determined by the company's performance, with a maximum of 100% if the revenue growth meets or exceeds the target [10]. Group 3: Unlocking Details - Of the 221 eligible participants, 214 achieved a performance score of 80 or above, allowing for a full unlock, while 7 participants scored between 70 and 80, resulting in a partial unlock [11][12]. - The total number of shares eligible for unlocking is 1,957,500, with specific allocations detailed for individual participants [12][13]. Group 4: Share Structure Changes - Following the unlocking, the total number of unrestricted shares increased from 508,217,624 to 510,175,124, while restricted shares decreased from 10,249,450 to 8,291,950 [15]. - The overall share structure remains compliant with listing requirements, indicating no significant impact on the company's equity distribution [15].